1. USANA reported Q4 and FY 2024 results with minimal Hiya operational impact. 2. USANA acquired a 78.8% stake in Hiya Health Products, indicating strategic growth.
The acquisition affected only a week of operations, keeping immediate financials stable, similar to other strategic acquisitions where benefits manifest later.
The acquisition indicates USANA's strategic expansion, which could be significant for future performance even though current effects are minimal.
While the acquisition had negligible short-term impact, such moves typically drive synergy and growth benefits over time.